Neovacs S.A. (EPA:ALNEV)
France flag France · Delayed Price · Currency is EUR
0.0017
-0.0002 (-10.53%)
Feb 12, 2026, 5:06 PM CET

Neovacs Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-4.36-32.91-8.74-3.55-11.84-6.14
Depreciation & Amortization
0.190.190.160.150.10.06
Loss (Gain) From Sale of Assets
-1.430.2500.18-
Asset Writedown & Restructuring Costs
-20.756.754.850.320-
Other Operating Activities
21.4821.48---0.110.13
Change in Other Net Operating Assets
0.34-0.541.56-1.371.760.31
Operating Cash Flow
-3.09-3.6-1.91-4.45-9.91-5.65
Capital Expenditures
-0.02-0.08-0.2-0.15-0.35-0.21
Sale (Purchase) of Intangibles
---0-0-0-
Investment in Securities
-1.411.53-10.87-31.4-18.46-0.02
Other Investing Activities
00-0---
Investing Cash Flow
-1.421.45-11.08-31.56-18.81-0.22
Long-Term Debt Issued
-1.096.19946.8514
Long-Term Debt Repaid
--1.52-5.05-8.83-46.16-13.76
Net Debt Issued (Repaid)
-0.23-0.431.140.170.690.24
Issuance of Common Stock
4.592.175.659.8151.0614.41
Other Financing Activities
-0.03-0.03----
Financing Cash Flow
4.331.76.799.9951.7514.65
Miscellaneous Cash Flow Adjustments
---00-0
Net Cash Flow
-0.19-0.45-6.2-26.0223.038.78
Free Cash Flow
-3.11-3.68-2.12-4.6-10.26-5.86
Free Cash Flow Margin
-1561.34%-848.26%-396.80%-413782.37%-45498.69%-19665.26%
Free Cash Flow Per Share
-6.53---0.02-5.15-0.01
Levered Free Cash Flow
-3.82-2.59-5.29-3.5-3.7-2.05
Unlevered Free Cash Flow
-3.41-2.59-5.29-3.5-3.7-2.05
Change in Working Capital
0.34-0.541.56-1.371.760.31
Source: S&P Global Market Intelligence. Standard template. Financial Sources.